Suppr超能文献

卵巢癌中与细胞凋亡相关的长链非编码RNA的机制

Mechanisms of Apoptosis-Related Long Non-coding RNAs in Ovarian Cancer.

作者信息

Takeiwa Toshihiko, Ikeda Kazuhiro, Horie-Inoue Kuniko, Inoue Satoshi

机构信息

Division of Systems Medicine & Gene Therapy, Saitama Medical University, Saitama, Japan.

Department of Systems Aging Science and Medicine, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.

出版信息

Front Cell Dev Biol. 2021 Apr 29;9:641963. doi: 10.3389/fcell.2021.641963. eCollection 2021.

Abstract

Ovarian cancer is a health-threatening malignancy of ovary in female reproductive systems and one of the most common gynecological malignancies worldwide. Due to rare early symptoms, ovarian cancers are often diagnosed at advanced stages and exhibit poor prognosis. Thus, efforts have been paid to develop alternative diagnostic and therapeutic strategies for the disease. Recent studies have presented that some long non-coding RNAs (lncRNAs) play roles in apoptosis of ovarian cancer cells through various mechanisms involved in the regulation of transcription factors, histone modification complexes, miRNAs, and protein stability. Because evasion of apoptosis in cancer cells facilitates to promote tumor progression and therapy resistance, apoptosis regulatory mechanisms of lncRNAs may be promising new targets in ovarian cancer. In this review, we introduce the recent findings in regard to the molecular mechanisms of apoptosis-related lncRNAs in ovarian cancer cells.

摘要

卵巢癌是女性生殖系统中一种威胁健康的卵巢恶性肿瘤,也是全球最常见的妇科恶性肿瘤之一。由于早期症状罕见,卵巢癌往往在晚期才被诊断出来,预后较差。因此,人们一直在努力开发针对该疾病的替代诊断和治疗策略。最近的研究表明,一些长链非编码RNA(lncRNAs)通过参与转录因子、组蛋白修饰复合物、微小RNA(miRNAs)和蛋白质稳定性调节的各种机制,在卵巢癌细胞的凋亡中发挥作用。由于癌细胞逃避凋亡有助于促进肿瘤进展和治疗耐药性,lncRNAs的凋亡调节机制可能是卵巢癌中有前景的新靶点。在这篇综述中,我们介绍了关于卵巢癌细胞中与凋亡相关的lncRNAs分子机制的最新研究结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c304/8117355/a6566573665a/fcell-09-641963-g001.jpg

相似文献

1
Mechanisms of Apoptosis-Related Long Non-coding RNAs in Ovarian Cancer.
Front Cell Dev Biol. 2021 Apr 29;9:641963. doi: 10.3389/fcell.2021.641963. eCollection 2021.
2
Long Non-Coding RNAs: the New Horizon of Gene Regulation in Ovarian Cancer.
Cell Physiol Biochem. 2017;44(3):948-966. doi: 10.1159/000485395. Epub 2017 Nov 27.
3
Identification of Novel Long Non-coding and Circular RNAs in Human Papillomavirus-Mediated Cervical Cancer.
Front Microbiol. 2017 Sep 19;8:1720. doi: 10.3389/fmicb.2017.01720. eCollection 2017.
4
Long non-coding RNAs involved in gynecological cancer.
Int J Gynecol Cancer. 2014 Sep;24(7):1140-5. doi: 10.1097/IGC.0000000000000212.
5
The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer.
Front Genet. 2021 Aug 20;12:693259. doi: 10.3389/fgene.2021.693259. eCollection 2021.
6
The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use.
Cancers (Basel). 2020 Apr 21;12(4):1020. doi: 10.3390/cancers12041020.
8
Involvement of non-coding RNAs in chemotherapy resistance of ovarian cancer.
J Cancer. 2018 Apr 30;9(11):1966-1972. doi: 10.7150/jca.24550. eCollection 2018.
9
RNA-based ovarian cancer research from 'a gene to systems biomedicine' perspective.
Syst Biol Reprod Med. 2017 Aug;63(4):219-238. doi: 10.1080/19396368.2017.1330368. Epub 2017 Jun 2.
10
The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Pathol Res Pract. 2018 Oct;214(10):1524-1531. doi: 10.1016/j.prp.2018.08.014. Epub 2018 Aug 20.

引用本文的文献

2
lncRNA-microRNA axis in cancer drug resistance: particular focus on signaling pathways.
Med Oncol. 2024 Jan 9;41(2):52. doi: 10.1007/s12032-023-02263-8.
4
Noncoding RNAs in apoptosis: identification and function.
Turk J Biol. 2021 Nov 14;46(1):1-40. doi: 10.3906/biy-2109-35. eCollection 2022.
6
7
Bibliometric analysis of hotspots and frontiers in cancer-related fatigue among ovarian cancer survivors.
PLoS One. 2022 Sep 22;17(9):e0274802. doi: 10.1371/journal.pone.0274802. eCollection 2022.

本文引用的文献

2
Long Non-coding RNAs Involved in Metabolic Alterations in Breast and Prostate Cancers.
Front Oncol. 2020 Oct 6;10:593200. doi: 10.3389/fonc.2020.593200. eCollection 2020.
4
NEAT1 Knockdown Suppresses the Cisplatin Resistance in Ovarian Cancer by Regulating miR-770-5p/PARP1 Axis.
Cancer Manag Res. 2020 Aug 14;12:7277-7289. doi: 10.2147/CMAR.S257311. eCollection 2020.
6
Long Noncoding RNAs Involved in the Endocrine Therapy Resistance of Breast Cancer.
Cancers (Basel). 2020 May 31;12(6):1424. doi: 10.3390/cancers12061424.
9
The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use.
Cancers (Basel). 2020 Apr 21;12(4):1020. doi: 10.3390/cancers12041020.
10
Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
J Cell Mol Med. 2020 Apr;24(7):4275-4285. doi: 10.1111/jcmm.15088. Epub 2020 Mar 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验